Functional analysis of Dnajc17 gene function: 
in vivo and in vitro studies by Pascarella, Angela
 1	  
UNIVERSITY OF NAPOLI FEDERICO II 
 
 
Doctorate School in Molecular Medicine 
 
Doctorate Program in 
Genetics and Molecular Medicine 
Coordinator: Prof. Lucio Nitsch 
XXVIII Cycle 
 
 
 
 
“Functional analysis of Dnajc17 gene function:  
in vivo and in vitro studies” 
 
 
 
 
 
CANDIDATE: Dr. Angela Pascarella 
MENTOR: Prof. Roberto Di Lauro 
 
 
 
 
 
 
 
 
Napoli 2016 
 2	  
TABLE OF CONTENTS 
ABSTRACT pag. 3 
1. BACKGROUND…………………………………………….. pag. 4-14 
1.1 Thyroid Gland development…………………………..…... pag. 4 
1.2 Molecular aspects of thyroid development……………….. pag. 4  
1.3 Congenital Hypothyroidism with Thyroid Dysgenesis and 
its Multigenic origin……………………………….…......... pag. 5 
1.4 Identification of candidate modifier genes….……..……… pag. 6 
1.5 DNAJC17 protein……………………………………..….… pag. 7 
1.6 Mouse preimplantation development………………...…… pag. 8 
1.7 Splicing mechanism…………………………………..….…. pag. 10 
1.8 Prp19/CDC5L complex………………………………...…... pag. 13 
1.9 Nuclear Speckles………………………………………..…... pag. 14 
2. AIM OF STUDY………………………………………..…..... pag. 15 
3. MATHERIALS AND METHODS……………………..….... pag. 16-20 
3.1 Establishment of Stable HeLa Cell Lines…………………. pag. 16 
3.2 Immunoblotting…………………………………………….. pag. 16 
3.3 Co-immunoprecipitation…………………………………… pag. 17 
3.4 In gel digestion, mass spectrometry analysis and protein 
identification…………………………………………...…... pag. 17 
3.5 Immunofluorescence Assay………………………………... pag. 18 
3.6 Image analysis………………………………………...…….. pag. 18 
3.7 RNA interference…………………………………………… pag. 18 
3.8 E1A splicing assay………………………………………….. pag. 19 
3.9 RNA sequencing……………………………………………. pag. 19 
3.10 Generation of Dnajc17 conditional knockout mouse….... pag. 20 
4. RESULTS………………………………………...…………... pag. 21-30 
4.1 Construction of DNAJC17 inducible-expression syste…... pag. 21 
4.2 DNAJC17 interactome includes several proteins involved 
in splicing ………………………………………………..… pag. 23 
4.3 DNAJC17 interacts with several splicing proteins in Vivo pag. 24 
4.4 DNAJC17 co-localizes with the splicing complex 35, a 
nuclear speckle molecular machinery marker…………... pag. 27 
4.5 E1A splicing assay………………………………………...... pag. 28 
4.6 RNA interference of Dnajc17…………………………...…. pag. 29 
4.7 Generation of Dnajc17 conditional knockout mouse…...... pag. 30 
5. DISCUSSION………………………………………………… pag. 31-32 
6. CONCLUSION………………………………………………. pag. 33 
7. REFERENCES………………………………………………. pag. 34-43 
 
 
 
 
 
 
 
 3	  
ABSTRACT 
 
Congenital hypothyroidism (CH) is the most frequent 
endocrinological congenital disorder often due to thyroid dysgenesis (TD). 
Mutations in genes involved in thyroid development such as Nxk2.1, Pax8, 
Foxe1, and Tshr cause TD in animal models, although in humans loss of 
function mutations in these genes have been identified only in few cases of CH 
with TD, suggesting the involvement of additional loci. A polygenic mouse 
model of CH with TD allowed our laboratory to identify Dnajc17, a member of 
the type III heat-shock protein-40 (Hsp40) family, as a candidate TD modifier 
gene. Our laboratory demonstrated that homozygous null mutation in Dnajc17 
gene are early embryo lethal.  
Moreover, as DNAJC17 is still poorly characterized, we started a detailed 
study in vitro. First, we studied its subcellular localization, showing that it 
localizes predominantly in the nucleus. Then, to uncover DNAJC17 function 
we used two different in vitro approaches: 1) analysis of DNAJC17 
interactome by CO-IP and mass spectrometry, 2) analysis of gene expression 
profile induced by Dnajc17 knock-down, both performed in HeLa cells. 
Interactome studies show that DNAJC17 interacts with several proteins 
involved in splicing. Some of these proteins are essential for embryonic 
development, similarly to Dnajc17 (PPR19, PLRG-1, snRNP200, XAB2). 
SNRNP200 (U5) is a component of the U5 snRNP and U4/U6-U5 tri-snRNP 
complexes and XAB2 that is involved in transcription-coupled repair and 
transcription. PRP19 and PLRG-1 belong to Prp19/CDC5L complex. 
Depletion of this complex leads to a block in splicing before the first 
transesterfication step in splicing and lariat formation of the pre-mRNA. 
Furthermore, the confirmation of DNAJC17 interaction with splicing 
machinery components comes from immunofluorescence demonstrating that 
DNAJC17 colocalize whith SC35, a spliceosome assembly factor localized in 
nuclear speckles. Consistently, gene expression profile of cells knocked-down 
for Dnajc17 displays alterations in the balance between alternatively spliced 
isoforms of many genes. We are currently characterizing differentially spliced 
genes. 
To elucidate the functional role of Dnajc17 in thyroid we generated a 
conditional knock-out mouse in which Dnajc17 has been disrupted specifically 
in the thyroid. 
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1.BACKGROUND 
 
1.1 Thyroid Gland development 
 
The thyroid anlage is first identified in mouse embryos at 
embryonic day E8.5 in the ventral wall of the primitive pharynx, caudal to the 
region of the first branchial arch. This median thickening deepens, forms first a 
small pit (thyroid bud). At this time, primitive thyroid cells already have a 
distinct molecular signature, with co-expression of four transcription factors 
Hhex, Tift1, Pax8 and Foxe1. 
At E9–E9.5 the endodermal cells of the thyroid anlage form the thyroid bud by 
proliferation and invasion of the surrounding mesenchyme. By E10, a small 
hole at the site of origin in the pharyngeal floor (the foramen cecum) is the 
remnant of the anlage, connected with the migrating thyroid primordium by a 
narrow channel (the thyroglossal duct). At E11.5 the thyroglossal duct 
disappears, and the thyroid primordium loses its connections with the floor of 
the pharynx and begins to expand laterally. Two days later the thyroid 
primordium reaches the trachea, which has extended ventrocaudally starting 
from the primitive laryngotracheal groove. By E15–E16 the thyroid lobes 
expand considerably, and the gland exhibits its definitive shape: two lobes 
connected by a narrow isthmus (De Felice and Di Lauro 2004) 
 
1.2 Molecular aspects of thyroid development 
 
The molecular basis of thyroid development begin with 
the investigation of a transcriptional factor, Nkx2.1, identified as responsible of  
Thyroglobulin (Tg)  and thyroperoxidase (Tpo) expression. Nkx2.1 was found 
expressed in adult and functional thyroid cells and in their precursor. 
Subsequently other three transcriptional factors was found expressed in thyroid 
precursor cells: Hhex, Pax8 and Foxe1.  
This four transcriptional factors are also expressed in other tissues, but their 
simultaneous presence is restricted at only thyroid cells since their 
specification to the rest of their life. 
Titf1/Nkx2.1 belongs to the Nkx2 family of transcriptional factors, was first 
identified as homeodomain-containing transcription factor able to bind to 
specific DNA sequences present in the Tg gene promoter. 
Titf1/Nkx2.1 knockout mice are characterized by lack of thyroid and death at 
birth (Kimura et al. 1996). The thyroid primordium forms in its correct position 
but subsequently undergoes degeneration and eventually disappears (Kimura et 
al. 1999). 
Pax8 (Paired box gene 8) is a transcriptional factor belongs to Pax family 
which nine members are characterized by a DNA binding domain named 
paired. 
The expression of this gene during embryo development is detected in thyroid 
since its specification (E8.5).  
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Pax8-/- mice are born with expected Mendelian frequency, but they show 
growth retardation and die in 2-3 weeks. The thyroid gland of this mice is 
severely affected because neither follicles nor TFCs can be detected, and the 
rudimentary gland is composed almost completely of calcitonin-producing C 
cells (Mansouri et al. 1998). 
Foxe1 was originally identified as a thyroid specific nuclear protein that 
recognizes a DNA sequence present on both Tg and TPO promoters under 
hormone stimulation (Civitareale et al. 1989, Santisteban et al. 1992). 
Expression of Foxe1 in the thyroid cell precursors is maintained during 
development and persists in adult TFCs (Zannini et al. 2001). 
Homozygous Foxe1-/- mice are born at the expected ratio but die within 48 h. 
These mice display no thyroid in its normal location and an absence of thyroid 
hormones. Furthermore, the mice show a severe cleft palate, probably 
responsible for the perinatal death, and elevated TSH levels in the bloodstream. 
The lack of Foxe1 doesn’t affects the thyroid primordium which is easily 
detected by the expression of Titf1/Nkx2-1 and Pax8. However, at E9.5 in 
Foxe1 null embryos, thyroid precursor cells are still on the floor of the pharynx 
and at later stages of development, mutant mice exhibit either a small thyroid 
remnant still attached to the pharyngeal floor or no thyroid gland at all (De 
Felice et al. 1998). 
Hhex is a transcription factor expressed from primordium to adult thyroid. This 
factor is fundamental for thyroid development, indeed Hhex-/- mice at E9.5 
show the absence of thyroid precursor, but the thyroid anlage is properly 
formed and expresses Titf1/Nkx2-1, Foxe1, and Pax8 (Martinez Barbera Et al. 
2000, De Felice and Di Lauro 2004). 
 
1.3 Congenital Hypothyroidism with Thyroid Dysgenesis and its 
Multigenic origin 
 
Congenital hypothyroidism (CH) is the most frequent 
endocrinological congenital disorders with a reported incidence of 1:1,500 live 
newborns. In a large fraction of CH thyroid dysfunction is due to thyroid 
dysgenesis (TD), including developmental disorders such as athyreosis, ectopy, 
hemiagenesis and hypoplasia. Mutations in genes involved in thyroid 
development such as Nxk2.1, Pax8, Foxe1, and Tshr cause TD in animal 
models, and loss of function mutations in the same genes are associated with 
TD in patients. Indeed, TD can be a genetic and heritable affection. However, 
mutations in these genes are present only in few patients affected by CH with 
TD, suggesting that other loci could be involved in the genesis of TD (Castanet 
et al. 2005; De Felice and Di Lauro 2004). 
To provide proof for a possible multigenic origin of TD a mouse model was 
generated. 
The null mutations generated in the genes encoding the transcription factors 
Titf1 and Pax8 only display a TD phenotype when homozygous. No phenotype 
was observed when these genes are in heterozygosity, but mice heterozygous 
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for both Titf1- and Pax8-null alleles, denominated DHTP (double heterozygous 
for both Titf1- and Pax8-null mutations), present TD. The disease is 
characterized by a small thyroid gland, elevated levels of TSH, reduced 
thyroglobulin biosynthesis, and high occurrence of hemiagenesis. 
TD condition is strain specific. TD is displayed when the DHTP mutations are 
in the C57BL/6 genetic background, and it is not observed in the 129/Sv strain 
(Amendola et al. 2005). The B6-specific TD phenotype of DHTP mice is 
associated with a reduced activation of a transgenic thyroglobulin (Tg) 
promoter, thus indicating that the modifier is acting on a transcriptional 
mechanism (Amendola et al. 2010).  
 
1.4 Identification of candidate modifier genes 
 
A genetic linkage analysis in a DHTP backcross 
population identified a potential locus linked to the B6-specific phenotypethe. 
This locus mapping on chromosome 2. On the basis of a single-nucleotide 
polymorphism (SNP) that causes a non synonymous amino acid change in a 
highly conserved protein domain between B6 and Sv strains, was identified 
Dnajc17, encoding for a member of the type III heat-shock protein-40 (Hsp40) 
family, as a candidate modifier gene for hypothyroidism. The B6 allele 
encodes for a protein containing a phenylalanine residue at position 273, 
whereas Sv mice contain a tyrosine in that position. The Sv129 variant is 
conserved in all species examined, from Drosophila to humans (Table 1). 
Table 1. Alignment of the deduced amino acid sequence of the C-terminal region of DNAJC17 
orthologous genes among different species. Tyrosine273 residue is in bold. Sequence data are according 
to the Ensembl data (Adapted from	  Amendola et al. 2010).  
 
Various data suggest this hypothesis. Dnajc17 is high expressed in both fetal 
and adult thyroid, affects Tg transcription and is essential in mouse embryo 
development. Indeed The Dnajc17+/- mice appeared normal, while Dnajc17-/- 
pups were never observed postnatally, indicating that the Dnajc17 null 
mutation is recessive embryonic lethal.  Only Dnajc17-/- two-cell embryos was 
found, but no homozygous embryos were recovered after the morula stage. 
These findings indicate that Dnajc17-/- embryos were developmentally arrested 
before implantation and indicate an essential role of this gene in early mouse 
development (Amendola et al. 2010). 
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Furthermore, Patel and collaborators identified a homozygous truncating 
mutation in DNAJC17 in a family with an apparently novel syndrome of 
retinitis pigmentosa and hypogammaglobulinemia (Patel N. et al. 2015). 
 
1.5 DNAJC17 protein 
 
DNAJC17 protein belong to Dnaj family, which 
canonical function is to stimulate the ATPase activity of molecular chaperone 
DNAJ/HSP70 in various cell function such protein folding, transport, 
degradation and heat shock response. 
All the members of the DnaJ/Hsp40 family contain the J domain through 
which they bind to their partner Hsp70s. This domain is usually present at the 
N-terminal region of the proteins. The J domain is a 70-amino acid sequence 
consisting of four helices and a loop region between helices II and III that 
contains a highly conserved tripeptide of histidine, proline, and aspartic acid 
(the HPD motif). In addition to the J domain, many DnaJ/Hsp40 proteins 
contain other conserved regions, which are critical to their functions. Based on 
the difference in these regions, DnaJ proteins can be categorized into three 
groups (Fig. 1). Type I proteins with the J domain, the Gly/Phe-rich region, and 
the cysteine repeats. Type II proteins possess the J domain and the Gly/Phe-
rich region, but lack the cysteine repeats. Type III proteins do not have any of 
these conserved regions other than the J domain. Although type I and II 
proteins are different in their conserved regions, it seems that both types 
function similarly and bind to non-native substrates. In contrast, the type III 
proteins may not bind to non-native polypeptides and thus should not function 
as molecular chaperones on their own (Qiu XB 2006).  
 
Figure 1. Classification of DnaJ/Hsp40 proteins. Depending on the presence of the Gly/Phe-rich region 
(G/F) and/or the cysteine repeats, a DnaJ/Hsp40 protein can be categorized as type I, II, or III. 
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DNAJC17 belongs to type III proteins and the three-dimensional structure 
prediction show that, the J domain is located near to the N-terminus, moreover 
there is an RNA recognition motif RRM located at  C-terminus of protein   
(Fig. 2). 
Figure 2. Schematic representation of DNAJC17 protein. The J domain is located near to the N-terminus 
and the RNA recognition motif (RRM) at  C-terminus of protein. The star represent thy273 localization. 
 
1.6 Mouse preimplantation development 
 
The period of preimplantation development in mouse, 
extending from egg fertilization to implantation of the blastocyst in the uterus, 
is a key stage during which the first three major cell lineages of the embryo and 
its extraembryonic membranes are set aside. These three lineages contribute to 
distinct tissues in later development: the epiblast (EPI) gives rise to the fetus 
itself; the trophectoderm (TE) goes on to form the majority of the fetal 
contribution to the placenta; and the primitive endoderm (PE) becomes the 
parietal and visceral endoderm, which later contributes to the yolk sac 
(Cockburn and Rossant 2010). 
 
 
Figure 3. Stages of preimplantation development. In the mouse, the fertilized egg undergoes three rounds 
of cleavage, producing an eight-cell embryo that then undergoes compaction. From the eight-cell stage 
onward, cell divisions produce two populations of cells, those that occupy the inside of the embryo and 
those that are located on the outside. The blastocoel cavity begins to form inside the embryo beginning at 
the 32-cell stage and continues to expand as the embryo grows and matures into the late blastocyst stage. 
Cdx2 becomes upregulated in outside, future TE cells, starting at the 32-cell stage, while Oct4 expression 
becomes limited to the ICM in the early blastocyst stage. By the late blastocyst stage, while continuing to 
express Oct4 ubiquitously, the ICM contains a population of Nanog-positive EPI cells and a population of 
Gata6-positive PE cells (Adapted from, Cockburn and Rossant 2010). 
  
The fertilized egg first undergoes a series of early cleavage divisions, 
producing increasing numbers of progressively smaller cells, known as 
blastomeres, without changing the overall size of the embryo (Fig. 3). Protein 
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synthesis in the mammalian zygote initially relies on a deposit of maternally 
loaded mRNA (Bachvarova 1985). Transcription of mRNA coded by the 
zygotic genome begins during the first few cleavage divisions. In mouse there 
is an initial burst of zygotic transcription at the end of the one-cell stage (Aoki 
et at. 1997; Hamatani et al. 2004). 
The early cleavage divisions produce an eight-cell embryo (morula stage) that 
subsequently undergoes an increase in intercellular adhesion known as 
compaction, causing all cells to adopt a more flattened morphology (Fig. 3). 
This process of compaction is essential for later morphogenetic events and for 
the proper segregation of the three embryonic lineages. In the mouse, 
compaction is associated with the formation of adherens and, later, tight 
junctions between cells. Blastomeres do not show any signs of intracellular 
polarity until compaction but, concomitant with the increase in cell adhesion at 
this stage, all cells rapidly polarize along the axis perpendicular to cell contact 
such that outward facing (apical) regions become distinct from inward facing 
(basolateral) regions.  
Once the eight-cell embryo has compacted and polarized, it undergoes two 
further rounds of cleavage, growing from eight cells to 16, and from 16 cells to 
32. During these divisions, inheritance of the polarized state is influenced by 
the orientation of the cleavage plane of the blastomere. If a cell undergoes 
mitosis at an angle perpendicular to its axis of polarity (that is, parallel to its 
inside-outside axis), its two daughter cells will both be polar and will remain 
on the outside of the embryo. However, cells can also divide parallel to their 
axis of polarity, producing one polarized outside daughter cell and one apolar 
cell that is located on the inside of the embryo (Johnson and Ziomek 1981; 
Sutherland et al. 1990). In this way the preimplantation embryo, which was 
previously composed of a uniform population of cells, has now generated two 
separate groups of cells: apolar inside cells and polar outside cells. 
From the 32-cell stage onward, these two cell populations have distinct 
developmental fates: cells on the outside of the embryo contribute to the TE 
lineage, while inside cells contribute to the inner cell mass (ICM), the group of 
cells that further diverges into the EPI and PE lineages. 
Starting at the 32-cell stage, as the outside cells of the embryo are becoming 
fully committed to the TE lineage (Dyce et al. 1987; Pedersen et al. 1986), a 
fluid-filled cavity known as the blastocoel begins to form (Fig. 3). The 
presence of a blastocoel is essential for proper development of the ICM 
(Pedersen et al. 1986). Once it begins to form, maintenance of the blastocoel 
depends on the epithelial character of the TE. 
With the formation of the blastocoel at E3.5, the mouse embryo is now 
considered a blastocyst. It continues to mature for an additional 24 hours and is 
ready to implant into the uterine wall by E4.5. 
TE and ICM lineage segregation is controlled by a small group of transcription 
factors. Specifically, Cdx2 is required for TE development, while the 
pluripotency markers octamer 3/4 (Oct4), Nanog, and SRYbox containing gene 
2 (Sox2) are involved in establishing the ICM fate. In the mouse, Cdx2 is 
 10	  
expressed at varying levels in all blastomeres starting at the eight-cell stage, 
but it becomes restricted to outside, future TE cells, prior to blastocyst 
formation (Fig. 3) (Dietrich and Hiirag 2007; Ralston and Rossant 2008; 
Cockburn and Rossant 2010).  
 
1.7 Splicing mechanism 
 
Most eukaryotic genes are expressed as precursor mRNA 
(pre-mRNA) that undergoes extensive modification and processing in the 
nucleus to convert it into mature mRNA for export to the cytoplasm, where it is 
subsequently translated into protein. An important processing step is the 
splicing, an essential step of gene expression in which noncoding sequences 
(introns) are removed and coding sequences (exons) are ligated together. 
Whereas some exons are constitutively spliced, many are alternatively spliced 
to generate variable forms of mRNA from a single pre-mRNA species. 
Alternative splicing is prevalent in higher eukaryotes and it enhances their 
complexity by increasing the number of unique proteins expressed from a 
single gene (Nilsen and Graveley 2010). Unraveling splicing at the molecular 
level is not only important for understanding gene expression, but it is also of 
medical relevance, as aberrant pre-mRNA splicing is the basis of many human 
diseases or contributes to their severity (Novoyatleva et al. 2006; Ward and 
Cooper 2010). 
Nuclear pre-mRNA splicing is catalyzed by the spliceosome, a large complex 
ribonucleoprotein (RNP) complex. Both the conformation and composition of 
the spliceosome are highly dynamic. 
Two unique spliceosomes coexist in most eukaryotes: the U2-dependent 
spliceosome, which catalyzes the removal of U2-type introns, and the less 
abundant U12-dependent spliceosome. this new spliceosome is structurally and 
functionally analogous to the well-characterized major-class splicing 
apparatus, it mediates the excision of a minor class of evolutionarily conserved 
introns that have non-canonical consensus sequences (reviewed by Patel and 
Steitz 2003; Will and Lührmann 2011). 
Information provided by a pre-mRNA that contributes to defining an intron is 
limited to short, conserved sequences at the 5′splice site (ss), 3′ss and branch 
site (BS) (Burge et al. 1999; Will and Lührmann 2011). The BS is typically 
located 18-40 nucleotides upstream from the 3'ss and in higher eukaryotes is 
followed by a polypyrimidine tract (PPT) (Fig. 4A). Different splice site and 
branch site sequences are found in U2- versus U12-type introns (Burge et al. 
1999). Additional, cis-acting pre-mRNA elements include exonic and intronic 
splicing enhancers (ESEs and ISEs) or silencers (ESSs and ISSs). They are 
typically short and diverse in sequence and modulate both constitutive and 
alternative splicing by binding regulatory proteins that either stimulate or 
repress the assembly of spliceosomal complexes at an adjacent splice site 
(Smith and Valcárcel 2000; Wang and Burge 2008; Will and Lührmann 2011). 
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Nuclear pre-mRNA introns are removed by two consecutive transesterification 
reactions (reviewed by Moore et al. 1993). First, the 2′OH group of the branch 
adenosine of the intron carries out a nucleophilic attack on the 5′ss. This results 
in cleavage at this site and ligation of the 5′end of the intron to the branch 
adenosine, forming a lariat structure. Second, the 3′ss is attacked by the 3′OH 
group of the 5′exon, leading to the ligation of the 5′and 3′exons (forming the 
mRNA), and release of the intron (Fig. 4A).  
 
Figure 4. Pre-mRNA splicing. (A) Schematic representation of the two-step mechanism of pre-mRNA 
splicing. Boxes and solid lines represent the exons (E1, E2) and the intron, respectively. The branch site 
adenosine is indicated by the letter A and the phosphate groups (p) at the 5′and 3′splice sites, which 
are conserved in the splicing products, are also shown. (Adapted from Will and Lührmann 2011). 
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Figure 5. Protein composition and snRNA secondary structures of the major human spliceosomal 
snRNPs. All seven Sm proteins (B/B’, D3, D2, D1, E, F, and G) or LSm proteins (Lsm2-8) are indicated 
by “Sm” or “LSm” at the top of the boxes showing the proteins associated with each snRNP. The 
U4/U6.U5 tri-snRNP contains two sets of Sm proteins and one set of LSm proteins (Adapted fromWill 
and Lührmann 2011). 
  
Assembly and functioning of the spliceosome requires approximately 100 
polypeptides and five small nuclear RNAs (snRNAs), not considering gene-
specific RNA-binding factors. The U2-dependent spliceosome is assembled 
from the U1, U2, U5, and U4/U6 snRNPs and numerous non-snRNP proteins. 
Each snRNP consists of an snRNA (or two in the case of U4/U6), a common 
set of seven Sm proteins (B/B′, D3, D2, D1, E, F, and G) and a variable 
number of particle-specific proteins (Will and Lührmann 2006; Will and 
Lührmann 2011) (Fig. 5). Assembly of the Sm proteins onto snRNA is a 
critical step of the biogenesis of the snRNP particles. Following export from 
the nucleus to the cytoplasm, each of the U1, U2, U4 and U5 snRNAs 
associates with one set of the Sm proteins to generate the snRNP core particle 
(henceforth termed Sm core RNP). Formation of the Sm core RNP is essential 
for the metabolic stability of the snRNP, as well as for the subsequent 
hypermethylation of the 5′cap from m7G to 2,2,7-trimethylguanosine, import 
of the particle into the nucleus and the recruitment of at least some particle-
specific proteins (Plessel et al. 1994). The spliceosomal snRNPs do not 
possesse a pre-formed active site and several of them are substantially 
remodeled in the course of splicing. 
Spliceosome assembly occurs by the ordered interaction of the spliceosomal 
snRNPs and numerous other splicing factors (reviewed by Brow 2002; Matlin 
and Moore 2007; Staley and Woolford 2009). In the event that an intron does 
not exceed ∼200–250 nts, the spliceosome initially assembles across the intron 
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(Fox-Walsh et al. 2005) (Fig. 4B). In the earliest cross-intron spliceosomal 
complex (i.e., the E complex), the U1 snRNP is recruited to the 5′ss and non-
snRNP factors such as SF1/mBBP and U2AF interact with the BS and PPT, 
respectively. In a subsequent step, the U2 snRNP stably associates with the BS, 
forming the A complex (also denoted prespliceosome). The U4/U6.U5 tri-
snRNP, which is pre-assembled from the U5 and U4/U6 snRNPs, is then 
recruited, generating the pre-catalytic B complex. Major rearrangements in 
RNA–RNA and RNA–protein interactions, leading to the destabilization of the 
U1 and U4 snRNPs, give rise to the activated spliceosome (i.e., the Bact 
complex). Subsequent catalytic activation by the DEAH-box RNA helicase 
Prp2, generates the B* complex, which catalyzes the first of the two steps of 
splicing. This yields the C complex, which in turn catalyzes the second step. 
The spliceosome then dissociates and, after additional remodeling, the released 
snRNPs take part in additional rounds of splicing (Will and Lührmann 2011). 
 
1.8 Prp19/CDC5L complex  
 
The protein composition of mammalian spliceosomes 
has been studied using complexes purified from HeLa nuclear extracts by a 
combination of gel filtration and affinity chromatography (Reed 1990; Bennett 
et al. 1992); mass spectrometry and database searches (Neubauer et al. 1998). 
A conserved subspliceosomal complex was identified and it is known as 
Prp19/CDC5L complex (Pso4-complex) in mammals (Ajuh et al. 2000; 
Makarova et al. 2002; Grote et al. 2010; Burns et al. 1999; Chen et al. 1999; 
McDonald et al. 1999). Depletion of this complex leads to a block in splicing 
before the first transesterfication step in splicing and lariat formation of the 
pre-mRNA (Makarova et al. 2002). Prp19/CDC5L complex consist of seven 
proteins: hPrp19, CDC5L, PRLG-1, AD002, SPF27, CTNNBL1 (β-catenin-
like 1), and HSP73 (Makarova et al. 2004). CDC5L, PRLG-1, PRP19, and 
SPF27 form a stable subcomplex of the hPrp19/CDC5L complex (Grote et al. 
2010). 
In mice the homozygous null mutation in prp19 gene is early embryo lethal. 
Indeed, homozigous knockout embryos die at the blastocyst stage 
(Fortschegger et al. 2007). Also the homozygous null mutation in PLRG-1 
gene is early embryo lethal (Kleinridders et al. 2009).  
snRNP200 (U5) is required for spliceosome assembly and its depletion can 
block the second step of splicing (Umen and Guthrie 1995). The omozigous 
knockout of snRNP200 induce complete embryonic lethality before 
implantation (J:204739 International Knockout Mouse Consortium, MGI 
download of modified allele data from IKMC and creation of new knockout 
alleles. Database Download. 2014).  
Another important protein in the splicing process is XAB2 (XPA-binding 
protein 2) is involved in the processes associated with cell cycle control and 
pre-mRNA splicing (Nakatsu et al. 2000; Dix et al. 1999; McDonald et al. 
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1999). XAB2-homozygous mutants could survive until the morula stage, but 
could not develop to the blastocyst stage (Yonemasu et al. 2005). 
 
1.9 Nuclear Speckles 
 
In mammalian cells the pre-mRNA splicing factors, 
including small nuclear ribonucleoprotein particles (snRNPs), spliceosome 
subunits, and other non-snRNP protein splicing factors, shows a punctate 
nuclear localization pattern that is usually termed “a speckled pattern” or 
named “SC35 domains” (Wansink et al. 1993). The speckles are located in the 
interchromatin regions of the nucleus. They usually appear as 20–50 irregularly 
shaped structures that vary in size.  
To targeting some of SR pre-mRNA splicing proteins to nuclear speckles is 
necessary and sufficient  the presence of arginine/serine-rich domain (RS 
domain) (Caceres et al. 1997; Hedley et al. 1995; Li et al. 1991). For speckle-
targeting have also been implicated the threonine-proline repeats of SF3b1 
(Eilbracht et al. 2001) and the forkhead-associated domain in NIPP1 (Jagiello 
et al. 2000) 
Although they apparently contain few, if any, genes speckles are often 
observed close to highly active transcription sites. This suggests that they 
likely have a functional relationship with gene expression, and some specific 
genes have been reported to preferentially localize near speckles (Brown et al. 
2008; Huang et al. 1991; Johnson et al. 2000; Moen et al. 2004; Smith et al. 
1999; Xing et al. 1993; Xing et al. 1995), 
However in the literature there are apparent discrepancies concerning the 
possible direct role of speckles as splicing sites. 
Although many in the field do not view speckles as direct transcription/pre-
mRNA splicing centers, others suggest that they may have a more direct role 
relating to the splicing and transport of pre-mRNA (reviewed in Hall et al. 
2006; Melcak et al. 2000; Shopland et al. 2002; Wei et al. 1999). 
Many pre-mRNA splicing factors, including snRNPs and SR proteins (Fu 
1995), have been localized to nuclear speckles. In addition, several kinases 
(Clk/STY, hPRP4, and PSKHI) (Brede et al. 2002; Colwill et al. 1996; Ko et 
al. 2001; Kojima et al. 2001; Sacco-Bubulya et al. 2002) and phosphatases 
(PP1) (Trinkle-Mulcahy et al. 1999; Trinkle-Mulcahy et al. 2001) that 
phosphorylate/dephosphorylate components of the splicing machinery have 
also been localized to nuclear speckles. 
The proteomic information, together with additional localization studies, has 
revealed that speckles contain many other proteins apart from pre-mRNA 
splicing factors. Of particular interest is the localization of transcription factors 
(Larsson et al. 1995; Mortillaro et al. 1996; Zeng et al. 1997), 3’-end RNA 
processing factors (Krause et al. 1994; Schul et al. 1998), eukaryotic 
translation initiation factor eIF4E (Dostie et al. 2000), eif4AIII, a protein 
involved in translation inhibition (Li et al. 1999), and structural proteins 
(Jagatheesan et al. 1999; Nakayasu and Ueda 1984; Sharma et al. 2010). 
 15	  
2. AIM OF STUDY 
 
Dnajc17 was identified as a candidate of congenital 
hypothyroidism (CH) with thyroid dysgenesis (TD) and the homozygous null 
mutation in DnajC17 gene are early embryo lethal. Embryonic lethality makes 
it difficult to study the functions of Dnjc17 in the various tissues. Thus, to 
elucidate the functional role of DNAJC17 in thyroid I generated a conditional 
knock-out mouse in which Dnajc17 has been disrupted specifically in the 
thyroid. 
Moreover, as DNAJC17 molecular function is unknown, I performed detailed 
characterization studies in vitro. To this purpose I used an inducible in vitro 
system cells exhibiting tetracycline-inducible expression of DNAJC17 fused to 
GFP protein (GFP-DNAJC17). This cell line allowed me to study the 
subcellular localization of Dnajc17,  its interactors and its targets. 
DNAJC17 cellular localization was studied by immunofluorescence assays.  
The interactors of DNAJC17 were identified by co-IP followed by Mass 
Spectrometry (MS). Interactors were then validated by co-immunoprecipitation 
and subcellular co-localization of DNAJC17 and its interactors was analyzed 
by Immunofluorescence Assays.  
As DNAJC17 has an RNA-recognition motif (RRM domain) and about one-
half of its interactors identified by MS are involved in splicing, I verified if 
Dnajc17 plays a role in gene expression and in the alternative mRNA splicing. 
For this purpose I performed an RNA-seq analysis in Dnajc17-depleted HeLa 
cells. The whole transcriptome of DNAJC17kd cells was compared with that of 
DNAJC17wt cells to identify up-regulated and down-regulated genes. The 
RNA-Seq data were also analyzed to identify alternatively-spliced genes 
differentially expressed between DNAJC17kd versus DNAJC17wt. I am 
currently confirming and characterizing differentially spliced genes.  
To analyze homozygous dnajc17 knockout embryos I setup a protocol to 
collect embryos at the morula stage. Total RNA obtained by collected embryos 
will be used to perform a RNA-Seq experiment to identify the genes altered by 
the absence of Dnajc17 and presumably responsible for the early embryo 
lethality of knockout mice. 
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3. MATHERIALS AND METHODS 
 
3.1 Establishment of Stable HeLa Cell Lines 
 
We used cDNA from sv129 mice tissue amplified by 
PCR with specific primers for Dnajc17. The resulting cDNA was used to 
obtain a fusion cDNA where Dnajc17 is in frame with GFP. Resulting chimeric 
cDNA and the cDNA containing only GFP were cloned into 
pCDNA5/FRT/TO (Invitrogen) to obtain stable HeLa cell lines exhibiting 
tetracycline-inducible expression of DNAJC17 tagged with GFP at the N-
terminus (GFP-DNAJC17 cells) or only GFP protein (GFP cells) from a 
specific genomic location. This is a 5.1 kb expression vector Contains a hybrid 
promoter consisting of the human cytomegalovirus immediate-early (CMV) 
promoter and tetracycline operator 2 (TetO2) sites for high-level tetracycline-
regulated expression in a wide range of mammalian cells. The TetO sites are 3' 
of transcription initiation at pCMV (downstream). TetO2 sequences consist of 
2 copies of the 19 nucleotide sequence: 5´-TCCCTATCAGTGATAGAGA-3´ 
separated by a 2 base pair spacer. It serves as binding sites for 4 Tet repressor 
molecules (comprising two Tet repressor homodimers). Contains a single FRT 
site immediately upstream of the hygromycin resistance gene for Flp 
recombinasemediated integration and selection of the pcDNA5/FRT/TO 
plasmid. Used in co-transfection into Flp-In T-REx HeLa host cells with 
pOG44 (Invitrogen) that contains the FLP gene encoding the Flp recombinase 
to mediate integration of the expression plasmid into the genome..	   Stable 
transfectants were selected by adding hygromycin to the culture medium 
 
3.2 Immunoblotting 
 
Whole-cell lysates of HeLa cells, GFP-DNAJC17 and 
GFP cells were prepared in sample buffer and normalized for equal protein 
concentration by Pierce BCA Protein Assay Kit (Thermo Scientific). A 20 µg 
amount of protein samples was resolved on a precast NuPAGE 4-12% Bis-Tris 
Gel (Life Technologies) and transferred on a polyvinylidene difluoride (PVDF) 
membrane (Millipore). Nonspecific binding sites were blocked by incubation 
with 5% nonfat dry milk in TBS (TrisHCl 20 MM pH 7.6, NaCl 140 mM) 
0.1% Tween 20. Immunodetection was performed by using rabbit polyclonal 
antibodies against DNAJC17, and monoclonal GFP antibody (Chromoteck). 
Immune complexes were detected by enhanced chemiluminescence as 
instructed by the manufacturer (Pierce). 
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3.3 Co-immunoprecipitation  
 
GFP-DNAJC17 fusion protein or GFP protein expression 
were induced 16h according to manufacturer instructions (Invitrogen K1020).  
4 confluent 15cm plates of GFP-DNAJC17 or GFP were harvested in PBS, 
Spin down for 5’ at 1000g and resuspended on 1 mL of Lysis buffer (50 mM 
Tris pH 7.4, 150 mM NaCl, 10mM EDTA, 2 mM MgCl2, 0.1% triton X100). 
After 30’ incubation in ice, extracts were passed several times through a 20g 
1and ½ needle. Protein extracts were clarified at 13000g for 10’ and transferred 
in clean tubes. 10 µL of GFP trap (chromotek gta-20) were added to the protein 
extract and the tubes were incubated in rotation for 2h at 4°C. GFP trap beads 
were pulled down at 1000g for 5’ and washed 5 times with washing buffer (50 
mM Tris pH 7.4, 200 mM NaCl, 10mM EDTA, 2 mM MgCl2, 0.1% triton 
X100). 
After the washes beads were boiled in 50 µL of 1X LDS (Invitrogen NP0008), 
1X sample reducing agent (Invitrogen NP0004). 5 µL of eluate for each sample 
were separated on 4-12% Bis-tris acrylamide gel (Invitrogen NP0321BOX) 
and silver stained. The remaining 45µL were stored for mass spectrometry 
protein identification. 
 
3.4 In gel digestion, mass spectrometry analysis and protein identification 
 
Eluated were separated by SDS-PAGE on a 12% gel, 
which was then stained with colloidal Coomassie G-250 (Candiano et al. 
2004). Gel image was acquired by using an Image Scanner III densitometer 
(GE Healthcare Life Sciences). Each lane corresponding to 0.2M, 0.3M and 
0.4M samples was manually cut into 23 slices. Slices were excised from gels, 
triturated and washed with water. Proteins were in-gel reduced, S-alkylated and 
digested with trypsin as previously reported [D’Ambrosio et al. 2008]. Digest 
aliquots were removed and subjected to a desalting/concentration step on  
ZipTip mC18 disk (Millipore) using 5% formic acid/50% acetonitrile as eluent 
before nanoLC-ESI-LIT-MS/MS analysis.  
Digests were analyzed by nanoLC-ESI-LIT-MS/MS using a LTQ XL mass 
spectrometer (Thermo Finnigan, San Jose, CA, USA) equipped with Proxeon 
nanospray source connected to an Easy-nanoLC (Proxeon, Odense, Denmark). 
Peptide mixtures were separated on an Easy C18 column (100 x 0.075 mm, 3 
mm) (Proxeon, Odense, Denmark) by using a linear gradient of acetonitrile 
containing 0.1% formic acid in aqueous 0.1% formic acid; acetonitrile was 
ramped from 5% to 40% over 60 min, and from 40% to 80% in 10 min, at a 
flow rate of 300 nL/min. Spectra were acquired the range m/z 400-2000. 
Acquisition was controlled by a data-dependent product ion scanning 
procedure over the three most abundant ions, enabling dynamic exclusion 
(repeat count 1 and exclusion duration 1 min). The mass isolation window and 
collision energy were set to m/z 3 and 35%, respectively. Duplicate analysis of 
each sample was performed.  
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Proteome Discoverer 1.3 platform (ThermoFisher, San Jose, CA, USA) was 
employed to search raw mass data against an updated mouse Uniprot non-
redundant sequence database (76058 protein sequences) using Mascot (Matrix 
Science, UK) algorithms by using a mass tolerance value of 2.0 Da for 
precursor ion and 0.8 Da for MS/MS fragments, trypsin as proteolytic enzyme, 
a missed cleavages maximum value of 2 and Cys carbamidomethylation as 
fixed modification, Met oxidation and pyro-Glu (N-term Q) variable 
modification. Candidates with more than 2 assigned unique peptides with an 
individual MASCOT score >25 were further considered for protein 
identification. 
3.5 Immunofluorescence Assay 
Cells were fixed with 3,7 % paraformaldehyde and 
permeabilized with PBS1X-Triton 0,1%. For detection of protein, we used 
rabbit polyclonal DNAJC17 antibody, PRP19 mouse polyclonal antibody 
(LifeSpan BioSciences), CDC5L mouse monoclonal anibody (Santa Cruz 
Biotechnology), PLRG-1 goat polyclonal antibody (Novus Biologicals), 
HELIC2 (snRNP 200) goat polyclonal antibody (Santa Cruz Biotechnology), 
SC-35 rabbit monoclonal antibody (Sigma). Secondary antibodies were mouse, 
human or goat IgG conjugated to a fluorochrome (Alexa Fluor). Antibody 
incubations were for 1 h at RT in PBS1X with BSA (2%) and Triton X-100 
(0.1%). Coverslips were mounted with mounting medium for fluorescence with 
DAPI (Vectashield) or DRAQ5 (Cell Signaling). Confocal microscopy and 
overlay analysis were performed on a Zeiss LSM510 Confocal Laser Scanning 
Microscope with a x63 objective. 
 
3.6 Image analysis 
 
Colocalization analysis was performed using JACoP 
plug-in embedded in the visualization and analysis software ImageJ (Bolte and 
Cordelières, 2006). Analysis was performed on a similar-sized symmetrical 
region of interest (ROI) selected for each dye. Each colored image was split 
into respective red, green, and blue channels. The comparative degree of 
colocalization was calculated as mean Pearson’s R coefficients and Coste’s 
randomization P value on the red and green channels using the embedded 
colocalization analysis plug-in at default settings .  
 
3.7 RNA interference 
 
The HeLa cell line was grown in Dulbecco’s modified 
Eagle medium (Euroclone) supplemented with 10% fetal calf serum (Hyclone). 
Cells were plated (18*10^4) in a 6 well plate in antibiotic-free complete 
medium and transfected the following day with 50nM Dnajc17 siRNA (ON-
TARGETplus Human Dnajc17 siRNA, cat n° L-021141) and 50 nM siRNA 
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negative control (ON-TARGETplus Non-targeting Pool, cat n° # D-001810) in 
INTERFERin transfection reagent (Polyplus 409-10) following the 
manufacturer’s protocol; three technical replicates were prepared for each 
condition. 
Cells were harvested 96 hours after transfection and total RNA was extracted 
for RNA-Seq transcriptome analysis. 
 
3.8 E1A splicing assay 
 
GFP-DNAJC17, HeLa-GFP or HeLa trasfected with 
specific siRNA to knockdown Dnajc17, were transfected with E1A minigene 
(Yang et al. 1994) using Lipofectamine 2000 (Invitrogen), according to 
manufacturer’s instruction. After transfection, at the medium was added or not 
2mg/ml of tetracycline and the cells were collected after 16hrs for RNA 
extraction. 1 mg of total DNA-free RNA was used for cDNA generation by 
using M–MLV reverse transcriptase (Promega). The oligos RT-PCR was 
performed as previously described (Yang et al. 1994). The specific primers 
used for RT-PCR were ElA569, 5'-ATTATCTGCCACGGAGGTGT-3'and 
ElA1315, 5'-GGATAGCAGGCGCCATTTTA-3'. 
 
 
3.9 RNA sequencing  
 
Differential gene expression was analysed in DNAJC17 
interfered HeLA cells by RNA sequencing (seq) approach. RNA was extracted 
from three independent samples for both knockdown and wild type conditions 
and sequenced on HiSeq1500 (Illumina) according to manufacturer’s 
protocols.  About 7x107 high quality sequence reads were produced for sample 
with a mean quality score ≥ 30 (99.9% base quality accuracy). The human 
Ensembl GRCh37 genome was used as reference for read mapping, performed 
by TopHat aligner (Trapnell et al. 2009). Properly mapped reads (about 5x107) 
were further processed using Cufflinks package (Trapnell et al. 2010). Selected 
reads were assembled in transcripts, which were compared among the six 
samples and with known annotations to generate a unique final transcriptome. 
Resulting 20825 genes were then tested for differential expression between 
DNAJC17kd vs  DNAJC17wt and filtered for corrected p-value (FDR) ≤ 0.05 
and absolute fold change ≥ 1.5 (884 significantly deregulated genes). In 
addition to the simple changes in gene expression, the RNA-Seq analysis 
allowed the identification of differentially spliced genes. All isoforms derived 
from the same pre-mRNA were investigated to calculate their relative 
abundance that represents the alternative splicing of the gene. This 
measurement was compared between the two conditions with Jensen-Shannon 
test to verify if in DNAJC17kd one or more splicing isoforms were more 
representative of the gene than in DNAJC17wt. The differential splicing test 
resulted significant for 287 genes (FDR ≤ 0.05). 
 20	  
 
3.10 Generation of Dnajc17 conditional knockout mouse 
 
The knock-in targeting vector to generate Dnajc17 
conditional KO  mice was purchased from EUCOMM CONSORTIUM 
http://www.eucomm.org (Fig. 6). The knock-in targeting vector contained a 
4605 bp 5’ homology arm, a FRT-flanked cassette driven by Dnajc17 promoter 
containing both a LacZ reporter gene and a neomycin resistance gene for 
positive selection (both separated by a LoxP sequence), 2 loxP sites flanking 
exon 2, 3 and 4 of Dnajc17 gene as well as a 4876 bp 3’ homology arm.  
Removal of the FRT cassette in the Dnajc17 knockin mice was achieved by 
constitutive FLP-mediated recombination. Subsequently, an additional round 
of breedings was performed in order to remove Flp transgene from the 
progeny. At this point, the resulting Dnajc17 loxP (floxed) mice were ready to 
be bred with Pax8-Cre mice (Bouchard et al. 2004). As a consequence of Cre-
mediated recombination of exon 2, 3 and 4, the Dnajc17 knockout transcript 
lacks exon 2, 3 and 4 mainly in thyroid and kidney. Absence of a protein in 
Dnajc17 conditional knockout mice will be verified by western blot and 
immunohistochemistry.  
 
Figure 6. knock-in targeting vector. 
 
Mouse genotyping was performed with genomic DNA samples isolated from tail biopsies that were taken 
from each animal at weaning. Standard PCR protocols were used to amplify the wildtype, knockin, floxed 
and knockout alleles of the Dnajc17 gene, as well as to detect the presence of Cre or Flp. The specific 
primers used in each case are indicated in table 2.  
 
Cre AACGCACTGATTTCGACC CAACACCATTTTTTCTGACCC 
Flp CACCTAAGGTCCTGGTTCGTCAGT CCAGATGCTTTCACCCTCACTTAG 
Wildtype and  
floxed GCTTGGCTAGTTCCACTA GGACAATGTGAAAGCCTAAGC 
knockin GCTTGGCTAGTTCCACTA CACAACGGGTTCTTCTGTTAGTCC 
Table 2. Mouse genotyping primers. 
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4. RESULTS 
 
4.1 Construction of DNAJC17 inducible-expression system 
 
The specific function of Dnajc17 is still poorly 
characterized, for this reason we generated an in vitro system cells exhibiting 
tetracycline-inducible expression of DNAJC17 fused to GFP protein (GFP-
DNAJC17). To obtain this cell line we used cDNA from sv129 mice tissue in 
Flp-In T-REx System (Flip In TRex, Invitrogen).  
In this system, expression of Gfp-Dnajc17 gene is repressed in the absence of 
tetracycline and induced in the presence of tetracycline. In the absence of 
tetracycline, the Tet repressor forms an homodimer that binds with extremely 
high affinity to each Tet operator (TetO2) sequence in the promoter controlling 
expression of the Gfp-Dnajc17 gene repressing the gene transcription. Upon 
addition, tetracycline binds with high affinity to each Tet repressor homodimer  
and causes a conformational change in the repressor that renders it unable to 
bind to the Tet operator.  
The Tet repressor:tetracycline complex then dissociates from the Tet operator 
allows induction of transcription from the Gfp-Dnajc17 gene (Fig. 7A). As 
control, we also generated stable HeLa cell lines exhibiting tetracycline-
inducible expression of GFP (GFP cells line). 
Western blot analysis of whole HeLa, GFP-DNAJC17 and GFP cells extracts 
(Fig 7B) and immunofluorescence (Fig. 7C) confirmed the expression of 
DNAJC17-GFP in a tetracycline dose-dependent manner. Immunofluorescence 
at the same time points confirmed the nuclear localization of DNAJC17-GFP 
while GFP alone localizes also in the cytoplasm (Fig. 7C). For all findings 
showed in this work we used 16h of tet treatment.  
 These data confirm not only the distinct nuclear localization of GFP-
DNAJC17 fused protein but allow me to use an in inducible in-vitro system to 
study the function of Dnajc17 gene. 
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Figure 7. HeLa cell lines exhibiting tetracycline-inducible expression of DNAJC17 fused to GFP protein 
or GFP. The binding of tetracycline to the Tet repressor that active the promoter controlling expression of 
the GFP-DNAJC17 gene (A). Expression of GFP-DNAJC17 and GFP gene is repressed in the absence of 
tetracycline and induced in the presence of tetracycline. Western blot analysis of whole HeLa, GFP-
DNAJC17 and GFP cells extracts (B) and immunofluorescence (C) confirmed the expression of GFP-
DNAJC17 in a tetracycline dose-dependent manner. Immunofluorescence at the same time points 
confirmed the nuclear localization of DNAJC17GFP while GFP alone localize also in the cytoplasm (C). 
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4.2 DNAJC17 interactome includes several proteins involved in splicing  
 
To identify DNAJC17 interacting proteins, we used 
GFP-DNAC17 cells and  GFP cells as negative control in Co-IP assay. GFP-
DNAJC17 fusion protein or GFP protein expression were induced 16h and 
whole lysate was immunoprecipitated using GFP trap beads (chromotek). 
Eluated were processed by mass spectrometry. 63 proteins were identified, and 
the apparent observed molecular mass and isoelectric point for all identified 
proteins matched very well with their calculated values. A Map of the 
Interactome Network shows the proteins interacting with DNAJC17 (Fig. 8).  
Figure 8. Map of the Interactome Network showing the proteins interating with GFP-DNAJC17 protein 
fusion (STRING software). 63 proteins was identified as interactors of DNAJC17. Most of these proteins 
could be classified into two general groups according to their cellular function: spliceosome and 
ribosome. 
  
Most of these proteins could be classified into two general groups according to 
their cellular function: spliceosome and ribosome. The largest group of 
proteins consists of factors involved in splicing. A total of 24 proteins have 
been identified within this category. Among these 24 proteins we identified 4 
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proteins playing essential roles in early embryogenesis similarly to Dnajc17 
(PPR19, PLRG-1, snRNP200, XAB2). (Tab. 3).  
 
 
Table 3. Proteins selected for validation. From mass spectrometry 4 proteins have been identified as splicing factors 
essential in embryogenesis like Dnajc17 (PRP19, PLRG-1, snRNP200, XAB2).  CDC5L belong to the Prp19/CDC5L 
complex and was identified in a human disease: the bilateral multicystic renal dysplasia. 
  
PLRG-1 and PRP19 are nuclear proteins component of a complex containing 
other splicing factors (Grote M et al., 2010; Ajuh et al., 2000; Burns et al., 
1999; Chen et al., 1999; McDonald et al., 1999; Neubauer et al., 1998). This 
conserved subspliceosomal complex is known as Prp19/CDC5L complex in 
mammals (Ajuh et al., 2000; Makarova et al., 2002; Grote M et al., 2010). 
Depletion of this complex leads to a block in splicing before the first 
transesterfication step in splicing and lariat formation of the pre-mRNA 
(Makarova et al., 2002). PRP19 e PLRG-1 belong to the subcomplex of the 
hPrp19/CDC5L complex consisting of CDC5L, PRLG1, PRP19, and SPF27 
(Grote M et al., 2010). Also CDC5L e SPF27 have been selected by mass 
spectrometry (Tab. 3). snRNP200 (U5) is required for spliceosome assembly 
and its depletion can block the second step of splicing (Umen JG, Guthrie C, 
1995). XAB2 (XPA-binding protein 2) is involved in the processes associated 
with cell cycle control and pre-mRNA splicing (Nakatsu et al., 2000; Dix et al., 
1999; McDonald et al., 1999). 
As DNAJC17 main localization is nuclear, we decided to focus on interactors 
involved in splicing. 
 
4.3 DNAJC17 interacts with several splicing proteins in Vivo 
 
To test whether the interactions observed in vitro by IP 
assays could be observed also in vivo, immunoprecipitation on whole protein 
extracts and co-immunofluorescence of HeLa modified cells were performed. 
GFP-DNAJC17 fusion protein or GFP were induced 16h and GFP trap beads 
was used to immunoprecipitate the recombinant proteins from the total protein 
extract prepared from GFP-DNAJC17 cells and from GFP cells used as 
control. 
Subsequently, the bound proteins were subjected to Western blot analysis after 
separation by SDS-PAGE. Western blot developed with a specific anti-target 
protein (Fig. 9) confirmed the presence of the tested interactors (PRP19, 
PLRG-1, CDC5L, snRNP200 and XAB2) in the co-immunoprecipitated 
proteins, only in the extract prepared from GFP-DNAJC17 cells treated with 
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tetracycline. 
 
 
 
Figure 9. Identification of DNAJC17-interacting partners. GFP-DNAJC17 and GFP cells were treated 
with tetracicline for 16h and cell lysates were immunoprecipitated with GFP-Trap®_A affinity beads 
(Chromoteck) and bound  proteins were eluted and analysed by Western blotting with the indicated 
antibodies. 
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Figure 10. Colocalization images in GFP-DNAJC17 cells. GFP-DNAJC17 cells stably transfected with 
GFP-DNAJC17 were induced with tetracycline end after 16h fixed and permeabilized. Each panel is 
composed of 4 images: the first one is GFP-DNAJC17; the red showing the staining with anti-PRP19, 
anti-CDC5L, anti-snRNP200 (u5) or anti-PLRG1 (secondary antibody: Alexa Fluor 555); the third image 
is a merged picture of GFP-DNAJC17 and the red-stained PRP19, CDC5L, snRNP200 or PLRG1. The 
last column shows a detail of the merged image. Colocalization is represented with increasing intensity of 
yellow in the third and last images. 
 
Furthermore, subcellular co-localization was observed by immunofluorescence 
(Fig. 10).  
Confocal images were analyzed with the ImageJ software using the JACoP 
plugin calculating the Pearson’s coefficient (Bolte and Cordelières, 2006) and 
following the Coste’s approach (Bolte and Cordelières, 2006). The 
immunofluorescence assay shows that DNAJC17 colocalizes with PRP19 
(mean Pearson’s coefficient: 0,805 ± 0,057; Coste’s randomization P value: 
100%), PLRG-1 (mean Pearson’s coefficient: 0,739 ± 0,050; Coste’s 
randomization P value: 100%), CDC5L (mean Pearson’s coefficient: manca da 
fare), snRNP200 (mean Pearson’s coefficient: 0,651 ± 0,057; Coste’s 
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randomization P value: 100%). These data confirm that DNAJC17 shares the 
same compartment of PRP19, PLRG-1, CDC5L and snRNP200 and suggest a 
possible role of DNAJC17 in modulating splicing activity.  
 
4.4 DNAJC17 co-localizes with the splicing complex 35, a nuclear speckle 
molecular machinery marker 
 
The nucleus contains various types of subnuclear 
structures, such as nucleoli, speckles particles, Cajal bodies, each having 
different nuclear activities. Based on the morphological appearance I 
speculated that DNAJC17 might be localized with the speckles that are nuclear 
domains enriched in pre-mRNA splicing factors, located in the interchromatin 
regions of the nucleoplasm of mammalian cells. An immunofluorescence 
analysis was performed on GFP-DNAJC17 cells, using SC35 as marker of 
nuclear speckles (Fig. 11). These findings establish that DNAJC17 co-localizes 
with SC35 (mean Pearson’s coefficient: 0,648 ± 0,035; Coste’s randomization 
P value: 100%). This data support the idea that DNAJC17 could be involved in 
maintaining folding and stability of proteins stored in the nuclear speckles 
dynamic complex and mainly involved in splicing machinery. Furthermore I 
also demonstrated by immunofluorescence on GFP-DNAJC17 cells that 
DNAJC17, SC35 and PRP19 colocalize (mean Pearson’s coefficient: 0,722 ± 
0,052; Coste’s randomization P value: 100%) (Fig. 11). DNAJC17 colocalizes 
with SC35 spekles and SC35 colocalizes with PRP19 that is a nuclear proteins 
component Prp19/CDC5L complex (Pso4-complex) in mammals. 
 
 
 
Figure 11. DNAJC17 and PRP19 colocalize with SC35 speckles. GFP-DNAJC17 cells stably transfected 
with GFP-DNAJC17 were induced with tetracycline end after 16h fixed and permeabilized. Cells were 
stained with anti-SC35 (upper image) or anti-PRP19 and anti-SC35 (lower image). The SC35 antibody 
was detected with Alexa Fluor 555, while the PRP19 antibody was detected with Alexa Fluor 647. 
Colocalization is represented with increasing intensity of yellow (upper) or pink (lower) in the third and 
last images. 
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4.5 E1A splicing assay 
 
To test whether DNAJC17 modulates alternative 
splicing, GFP-DNAJC17 and GFP cells, as a control, were transfected with 
E1A minigene (Yang et al. 1994) in presence (+) or not (-) of tetracycline. RT-
PCR analysis showed that overexpression of DNAJC17-GFP did not alter E1A 
alternative splicing (Fig. 12A). 
 
 
 
Figure 12 . In vivo splicing assays using GFP-DNAJC17, GFP and DNACJ17-depleted HeLa cells. GFP-
DNAJC17 and  GFP cells, as a control, were transfected with E1A minigene in presence (+) or not (-) of 
tetracicline. Total RNA was extracted and analyzed for ElA splicing by RT-PCR (A). HeLa cells were 
transfected with specific siRNA to knockdown DNAJC17 (DNAJC17kd) or with scrambles as control 
(DNAJC17wt). After 24h the cells were transfected with E1A minigene. Total RNA was extracted and 
analyzed for ElA splicing by RT-PCR. 
  
This assay was performed also by RNA interference approach. HeLa cells were 
transfected with specific siRNA to knockdown DNAJC17 (DNAJC17kd), or 
with scrambles as control (DNAJC17wt), after 48h the cells were transfected 
with E1A minigene. PCR analysis following 96h after siRNA trasfection 
showed that silencing of Dnajc17 did not alter E1A alternative splicing (Fig. 
12B). Although, this result suggest that DNAJC17 was not directly involved in	  
in splicing regulation of E1A gene, its role in alternative splicing process can 
not be excluded. 
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4.6 RNA interference of Dnajc17 
 
To test wether DNACJ17 could have an impact in the 
splicing on the whole transcriptome, I performed RNA-Seq analysis in HeLa 
cells depleted of DNACJ17 by RNA interference. To this aim, HeLa cells were 
transfected with specific siRNA to knockdown Dnajc17. The Western blot 
analysis following 96h of trasfection revealed the specific decline of protein for 
siRNA induced Dnajc17 knockdown (DNAJC17kd) as compared to its wild 
type counterpart treated with scramble (DNAJC17wt) (Fig. 13).  
 
 
 
 
Figure 13. Westernblot analysis of RNA interference. HeLa cells were transduced with specific siRNA to 
knockdown DNAJC17. The Western blot analysis following 96h of transfection revealed the specific 
decline of protein for siRNA induced Dnajc17 knockdown (DNAJC17kd) as compared to its wild type 
counterpart treated with scramble (DNAJC17wt).   
 
The effect of Dnajc17 silencing on global gene expression was investigated by 
high-throughput sequencing of RNA (RNA-Seq) and the whole transcriptome 
of DNAJC17kd cells was compared to that of DNAJC17wt cells . Three 
replicates for both conditions were sequenced producing about 7 x 107 reads 
for sample, that were mapped to reference genome (Homo sapiens, GRCh37) 
using TopHat aligner (Trapnell et al, 2009). Correctly mapped reeds were then 
processed by Cufflinks (Trapnell et al, 2010) to assembly genes and transcripts  
and to calculate their relative expression levels. A total of 20825 assembled 
genes were selected (removing those with too low aligned reads) and further 
analysed to test differential expression. Genes with corrected p-value ≤ 0.05 
and absolute fold change ≥ 1.5 were differentially expressed in knockdown 
cells compared to wild type. The resulting 359 up-regulated and 525 down-
regulated genes represent the significant variation of expression profile in 
response to Dnajc17 silencing. 
 
 30	  
 
Figure 14. RNA-Seq analysis. 
 
Furthermore, sequencing analysis of transcriptome allows to investigate also 
qualitative differences across the samples. The expression levels of the 
isoforms produced by alternative splicing of a single transcript were compared 
between DNAJC17kd and DNAJC17wt. This analysis identified 287 significant 
differentially spliced genes, showing that Dnajc17 silencing affected the 
alternative splicing, and suggesting a critical role of DNAJC17 in primary 
transcripts processing (Fig. 14). 
 
4.7 Generation of Dnajc17 conditional knockout mouse 
 
To study the in vivo role of this Dnajc17, we generated a 
Dnajc17 conditional KO. The knock-in targeting vector contained a 4605 bp 5’ 
homology arm, a FRT-flanked cassette driven by promoter containing both a 
LacZ reporter gene and a neomycin resistance gene for positive selection (both 
separated by a LoxP sequence), 2 loxP sites flanking exon 2, 3 and 4 of 
Dnajc17 gene as well as a 4876 bp 3’ homology arm. Removal of the FRT 
cassette in the Dnajc17 knockin mice was achieved by constitutive FLP-
mediated recombination. Subsequently, an additional round of breedings was 
performed in order to remove Flp transgene from the progeny. The resulting 
Dnajc17 loxP (floxed) mice appear normal and fertile.  
At this point, the resulting Dnajc17 loxP (floxed) mice were ready to be bred 
with Pax8-Cre mice (Bouchard et al. 2004). As a consequence of Cre-mediated 
recombination of exon 2, 3 and 4, the Dnajc17 knockout transcript lacks exon 
2, 3 and 4 mainly in thyroid and kidney. Absence of a DNAJC17 protein in 
Dnajc17 conditional knockout mice will be verified by western blot and 
immunohistochemistry. 
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5. DISCUSSION 
 
Congenital hypothyroidism (CH) is the most frequent 
endocrinological congenital disorder often due to thyroid dysgenesis (TD). 
Mutations in genes involved in thyroid development such as Nxk2.1, Pax8, 
Foxe1, and Tshr cause TD in animal models, although in humans loss of 
function mutations in these genes have been identified only in few cases of CH 
with TD, suggesting the involvement of additional loci. A polygenic mouse 
model of CH with TD allowed our laboratory to identify Dnajc17 as a 
candidate TD modifier gene.  
Furthermore, an homozygous truncating mutation in Dnajc17 has been 
identified in a family with an apparently novel syndrome of retinitis 
pigmentosa and hypogammaglobulinemia (Patel N. et al. 2015). Suggesting the 
important role of DNAJC17 in different cellular processes.  
The homozygous null mutation in Dnajc17 gene are early embryo lethal.  In 
particular, only Dnajc17-/- two-cell embryos were found, but no homozygous 
embryos were recovered after the morula stage. These findings indicate that 
Dnajc17-/- embryos were developmentally arrested before implantation and 
indicate an essential role of this gene in early mouse development (Amendola 
E. et al. 2010). 
DNAJC17 protein is a member of the type III heat-shock protein-40 (Hsp40) 
family. Canonical function of Dnaj family is to stimulate the ATPase activity 
of molecular chaperone DNAJ/HSP70 in various cell function such protein 
folding, transport, degradation and heat shock response. 
Type III proteins have only the J domain as conserved regions. These proteins 
may not bind to non-native polypeptides and thus should not function as 
molecular chaperones on their own (Qiu XB 2006). 
DNAJC17 three-dimensional structure prediction show that, the J domain is 
located near to the N-terminus, moreover there is an RNA recognition motif 
RRM located at  C-terminus of protein (Fig.2). 
In this thesis work, I performed in vitro studies to shed light on the function of 
Dnajc17, which is still uncharacterized. In this work, DNAJC17 interactome 
analysis by CO-IP and mass spectrometry demonstrates that DNAJC17 
interacts with 63 proteins. Most of these proteins could be classified into two 
general groups according to their cellular function: spliceosome and ribosome. 
The largest group of proteins consisting of factors involved in splicing. A total 
of 24 proteins have been identified within this category. Among these 24 
proteins we identified 4 that form a stable subcomplex of the hPrp19/CDC5L 
complex (CDC5L, PRLG-1, PRP19, and SPF27). Depletion of this complex 
leads to a block in splicing before the first transesterfication step in splicing 
and lariat formation of the pre-mRNA (Grote et al. 2010; Makarova et al. 
2002). Furthermore, CDC5L, PRLG1 and PRP19 are essential proteins in 
embryogenesis like Dnajc17. The interaction and colocalization of DNAJC17 
with CDC5L, PRLG-1 and PRP19 was confirmed with CO-IP and 
immunofluorescence essay. The interaction with the core of the 
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hPrp19/CDC5L complex suggest a possible involment of DNAJC17 in the 
correct formation or function of the complex. 
snRNP200 (U5) was another protein identified among DNAJC17 interactors. 
This protein is required for spliceosome assembly and its depletion can block 
the second step of splicing (Umen and Guthrie 1995). The homozygous 
knockout of snRNP200 induces complete embryonic lethality before 
implantation.  
These data suggest the involvement of DNAJC17 in splicing mechanism.  
Based on the interaction of DNAJC17 with several proteins involved in 
splicing and on the analysis of the morphological appearance of DNAJC17 
localization, I speculated that DNAJC17 might be localized within the nuclear 
speckles. I confirmed this hypothesis by immunofluorescence assay that 
demonstrated the colocalization between DNAJC17 and SC35, a spliceosome 
assembly factor localized in nuclear speckles. Furthermore, DNAJC17 
localizes in nucleus.  
Taken together  these data support the idea that DNAJC17 could be involved in 
maintaining folding and stability of proteins stored in the nuclear speckles 
dynamic complex and mainly involved in splicing machinery 
However, the E1A minigene splicing assay performed either with 
overexpression or knockdown of DNAJC17 gave negative results. This does 
not excludes that DNAJC17 could play a role in the splicing process, as 
DNAJC17 might bind specific RNA sequences that are not present in E1A 
minigene, or it might regulates specific splicing factors that are not involved in 
E1A splicing regulation. An investigation beyond the scope of this study is 
required to demonstrate the direct role/involvement of DNAJC17 in alternative 
splicing.  
The role of DNAJC17 in gene expression regulation was investigated by RNA 
interference approach. Sequencing analysis of transcriptome from DNAJC17-
interfered cells shows 359 up-regulated and 525 down-regulated genes 
showing significant variation of expression level in response to Dnajc17 
silencing.  
Finally, sequencing analysis of expression levels of the isoforms produced by 
alternative splicing of a single transcript were compared between DNAJC17kd 
versus DNAJC17wt. This analysis identified 287 significant differentially 
spliced genes, showing that Dnajc17 silencing affected alternative splicing.  
These findings suggest a critical role of DNAJC17 in primary transcripts 
processing.  
Furthermore, to elucidate the functional role of DNAJC17 in thyroid I 
generated a conditional knock-out mouse in which Dnajc17 has been disrupted 
specifically in the thyroid. I am currently studying the involvement of Dnajc17 
in thyroid gland development and physiology. 
Finally, to understand the involvement of DNAJC17 in embryonic 
development I am collecting embryos at the morula stage to analyze 
homozygous Dnajc17 KO embryos. After the collection, I plan to perform a 
RNA-Seq experiment to identify the genes altered by the absence of Dnajc17. 
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6. CONCLUSION 
 
The work described in this thesis is the first attempt to unveil the molecular 
function of DNAJC17, a housekeeping gene still poorly characterized, The 
interest for this gene stems from previous studies that identified Dnajc17 as a 
potential modifier gene for CH, highlighting also its essential role in early 
embryogenesis (Amendola et al. 2010).  
Here we characterized DNAJC17 interactome, showing that a large number of 
its interactors are components of the splicing machinery. We also analyzed  the 
modifications of gene expression profiles induced by DNAJC17 knockdown, 
including many differentially spliced transcripts. Taken together, these results 
strongly suggest that DNAJC17 protein could play a role in the regulation of 
gene expression possibly by interacting with proteins involved in splicing.  
Several experiments are still in progress, including: 1) detailed study of the 
transcripts spliced differentially in the absence of Dnajc17, 2) generation and 
characterization of conditional Dnajc17 knock-out mouse, 3) collection of 
Dnajc17 KO morulae for the analysis of gene expression profiles.   
The completion of these studies both in vitro and in vivo, will be essential to 
elucidate both the role played by Dnajc17 in thyroid and in whole embryo 
development, and to clarify the molecular mechanisms underlying its 
biological function. 
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